Synaffix is a Dutch biotechnology company headquartered in the Netherlands that has developed a clinical-stage platform technology for antibody-drug conjugates (ADCs) which are used primarily in the treatment of cancer. ADCs utilize potent small molecule payloads, similar to those used for chemotherapy, but are designed to target only the cancer cells and spare normal, healthy tissues. The proprietary technology of Synaffix was developed to enable the treatment of a wide variety of cancer types and is designed to significantly enhance the effectiveness while also improving the safety and tolerability of these targeted cancer therapeutics. More information...
According to PR-model, synaffix.com is ranked 1,873,062nd in multilingual Wikipedia, in particular this website is ranked 1,037,074th in English Wikipedia.
The website is placed before wsto.tv and after muaythaiplaza2004.com in the BestRef global ranking of the most important sources of Wikipedia.
